Cherubino Ltd. secures contract for Medicinal products used in diabetes - CT2373/2024 - TENDER FOR THE SUPPLY OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS

Malta, Dec. 22 -- Malta based Cherubino Ltd. has secured contract from Department of Contracts for Medicinal products used in diabetes - CT2373/2024 - TENDER FOR THE SUPPLY OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS. The value of the contract is worth 54780000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....